. 2020 Jan 14;41(6):866–878. doi: 10.1038/s41401-019-0342-5

Table 1.

Comparative antibacterial activity of ETM, GM, and AMK against 36 susceptible bacterial clinical isolates.

	E. coli (n = 6)			K. pneumoniae (n = 6)			E. cloacae (n = 6)			P. mirabilis (n = 6)			P. aeruginosa (n = 6)			S. aureus (n = 6)
Antibiotics	MIC_range	MIC₅₀	MIC₉₀	MIC_range	MIC₅₀	MIC₉₀	MIC_range	MIC₅₀	MIC₉₀	MIC_range	MIC₅₀	MIC₉₀	MIC_range	MIC₅₀	MIC₉₀	MIC_range	MIC₅₀	MIC₉₀
GM	1–4	1	3	0.5–128	0.75	64.5	0.5–4	1	2.5	0.5–8	1	5	≤0.25 to 2	0.5	1.6	≤0.25 to 64	0.75	48
AMK	1–8	4	6	0.5–2	1	2	0.5–2	1	2	2–64	4	36	0.5–16	1	22.4	0.5–32	4	17.6
ETM	≤0.25 to 1	0.75	1	≤0.25 to 16	≤0.25	≤0.25	≤0.25 to 0.5	≤0.25	≤0.25	0.5–8	0.5	4.5	≤0.25 to 0.5	0.5	0.5	≤0.25 to 16	1.25	11.8

MICs are expressed in μg/mL.

MIC₅₀ and MIC₉₀ = the concentrations at which 50% and 90% of the isolates are inhibited